Church & Dwight Co CHD · USD
Consumer Staples · Household Products · US listing · 🇺🇸 United States
S&P 500
111.31
+1.81%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
Church & Dwight Co annual report
Filed with the US Securities and Exchange Commission
The latest annual report covers the year to 31 Dec 2025, filed on 12 Feb 2026.
Read the 10-K on SEC.gov ↗Five-year highlights
In USD.
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Revenue | $6.20bn | $6.11bn | $5.87bn | $5.38bn | $5.19bn |
| Operating income | $1.05bn | $807.1m | $1.17bn | $597.8m | $1.08bn |
| Net income | $736.8m | $585.3m | $755.6m | $413.9m | $827.5m |
| Free cash flow | $1.09bn | $976.4m | $807.1m | $706.4m | $875.0m |
| Total assets | $8.91bn | $8.88bn | $8.57bn | $8.35bn | $8.00bn |
| Shareholders' equity | $4.00bn | $4.36bn | $3.86bn | $3.49bn | $3.23bn |
Revenue by business
Year to 31 Dec 2017
- Household products. $1.64bn · 43.4%
- Personal care products. $1.21bn · 32.2%
From the 2025 annual report
As filed, for the year to Dec. 31, 2025. A later report may be linked above: this is the newest our data supplier has processed.
Income statement USD ($) $ in Millions
| Dec. 31, 2025 | Dec. 31, 2024 | Dec. 31, 2023 | |
|---|---|---|---|
| Net Sales | 6,203.2 | 6,107.1 | 5,867.9 |
| Cost of sales | 3,428.4 | 3,317 | 3,279.4 |
| Gross Profit | 2,774.8 | 2,790.1 | 2,588.5 |
| Marketing expenses | 708.9 | 698.1 | 641.3 |
| Selling, general and administrative expenses | 988.3 | 927.8 | 889.8 |
| VMS Trade name and other asset impairments | — | 357.1 | — |
| Income from Operations | 1,077.6 | 807.1 | 1,057.4 |
| Equity in earnings of affiliates | 7.9 | 9.1 | 8.7 |
| Interest income | 23.5 | 26.3 | 13 |
| Interest expense | -95.2 | -95 | -110.9 |
| Other income (expense), net | -56.9 | 8.8 | -0.8 |
| Income before Income Taxes | 956.9 | 756.3 | 967.4 |
| Income taxes | 220.1 | 171 | 211.8 |
| Net Income | 736.8 | 585.3 | 755.6 |
| Weighted average shares outstanding - Basic | 242,700,000 | 244,400,000 | 244,900,000 |
| Weighted average shares outstanding - Diluted | 244,300,000 | 246,900,000 | 247,600,000 |
| Net income per share - Basic | 3.04 | 2.39 | 3.09 |
| Net income per share - Diluted | 3.02 | 2.37 | 3.05 |
| Cash dividends per share | 1.18 | 1.13 | 1.09 |
| VMS Trade name and other asset impairments | 0 | 357.1 | 0 |
Balance sheet USD ($) $ in Millions
| Cash and cash equivalents | 409 | — | 964.1 | ||
|---|---|---|---|---|---|
| Accounts receivable, less allowances of $3.7 and $5.1 | 593.4 | — | 600.8 | ||
| Inventories | 534.8 | — | 613.3 | ||
| Other current assets | 59.8 | — | 62.4 | ||
| Total Current Assets | 1,597 | — | 2,240.6 | ||
| Property, Plant and Equipment, Net | 822.8 | [1] | 931.7 | ||
| Equity Investment in Affiliates | 10.3 | — | 11.1 | ||
| Trade Names and Other Intangibles, Net | 3,511.5 | — | 2,888.5 | ||
| Goodwill | 2,627.5 | — | 2,433.2 | ||
| Other Assets | 343.3 | — | 378 | ||
| Total Assets | 8,912.4 | — | 8,883.1 | ||
| Accounts payable | 732.4 | — | 705.1 | ||
| Accrued expenses and other liabilities | 583 | — | 605.5 | ||
| Business acquisition liabilities | 178.9 | — | 0 | ||
| Income taxes payable | 3.4 | — | 5.3 | ||
| Total Current Liabilities | 1,497.7 | — | 1,315.9 | ||
| Long-term Debt | 2,205.1 | — | 2,204.6 | ||
| Deferred Income Taxes | 886.9 | — | 669.2 | ||
| Deferred and Other Long-term Liabilities | 320.5 | — | 332.6 | ||
| Total Liabilities | 4,910.2 | — | 4,522.3 | ||
| Preferred Stock, $1.00 par value, Authorized 2,500,000 shares; none issued | 0 | — | 0 | ||
| Common Stock, $1.00 par value, Authorized 600,000,000 shares; 293,709,982 shares issued as of December 31, 2025 and 2024 | 293.7 | — | 293.7 | ||
| Additional paid-in capital | 625.1 | — | 563.1 | ||
| Retained earnings | 6,768.2 | — | 6,319.7 | ||
| Accumulated other comprehensive loss | -19.9 | — | -30.9 | ||
| Common stock in treasury, at cost: 57,156,105 shares as of December 31, 2025 and 47,830,141 shares as of December 31, 2024 | -3,664.9 | — | -2,784.8 | ||
| Total Stockholders' Equity | 4,002.2 | — | 4,360.8 | ||
| Total Liabilities and Stockholders’ Equity | 8,912.4 | — | 8,883.1 | ||
| [1] In connection with the VMS divestiture as described in Note 7, the Company divested PP&E with a gross value of $223.1 and a net book value of $142.9 in December of 2025. | — | — | — | [1] | In connection with the VMS divestiture as described in Note 7, the Company divested PP&E with a gross value of $223.1 and a net book value of $142.9 in December of 2025. |
| [1] | In connection with the VMS divestiture as described in Note 7, the Company divested PP&E with a gross value of $223.1 and a net book value of $142.9 in December of 2025. |
Cash flow statement USD ($) $ in Millions
| Dec. 31, 2025 | Dec. 31, 2024 | Dec. 31, 2023 | |
|---|---|---|---|
| Net Income (Loss) | 736.8 | 585.3 | 755.6 |
| Depreciation expense | 89.7 | 83.2 | 72.8 |
| Amortization expense | 157.7 | 155.9 | 152.4 |
| Change in fair value of business acquisition liabilities | 19 | 0 | 0 |
| Deferred income taxes | 36 | -82 | -13.8 |
| Business exit related impairments | 45.6 | 0 | 0 |
| VMS Trade name and other asset impairments | — | 357.1 | — |
| Loss on sale of vitamin business | 58.5 | 0 | 0 |
| Equity in net earnings of affiliates | -7.9 | -9.1 | -8.7 |
| Distributions from unconsolidated affiliates | 8.8 | 8.9 | 9.5 |
| Non-cash compensation expense | 58 | 59.2 | 63.6 |
| Asset impairment charge and other asset write-offs | 10.1 | 12.1 | 8.9 |
| Other | -6.7 | -6.2 | -0.4 |
| Subtotal | 1,205.6 | 1,164.4 | 1,039.9 |
| Accounts receivable | 39.4 | -81.5 | -97.4 |
| Inventories | 56.1 | 2 | 38.5 |
| Other current assets | 1.2 | -0.5 | 10.4 |
| Accounts payable | 2.4 | 98.6 | -58.1 |
| Accrued expenses | -60.9 | -1.1 | 113.3 |
| Income taxes payable | -5.1 | -7.1 | -1.8 |
| Other operating assets and liabilities, net | -23.3 | -18.6 | -14.2 |
| Change in Working Capital | 9.8 | -8.2 | -9.3 |
| Net Cash Provided By Operating Activities | 1,215.4 | 1,156.2 | 1,030.6 |
| Additions to property, plant and equipment | -122.4 | -179.8 | -223.5 |
| Acquisitions | -656 | -19.9 | 0 |
| Proceeds from Sale of Passport | 0 | 6.6 | 0 |
| Proceeds from Sale of Vitamin Business | 160.3 | 0 | 0 |
| Other | 1.2 | 9.8 | -10.8 |
| Net Cash Used In Investing Activities | -616.9 | -183.3 | -234.3 |
| Repayments of long-term debt | 0 | -204.6 | -200 |
| Short-term debt (repayments), net of borrowings | 0 | -3.6 | -70.6 |
| Proceeds from stock options exercised | 35.6 | 142.9 | 111.7 |
| Payment of cash dividends | -287.2 | -277 | -266.5 |
| Purchase of treasury stock | -900 | 0 | -300.1 |
| Payment of business acquisition liability | -5.9 | 0 | 0 |
| Other | -4.9 | -1.1 | -0.1 |
| Net Cash Used In Financing Activities | -1,162.4 | -343.4 | -725.6 |
| Effect of exchange rate changes on cash and cash equivalents | 8.8 | -9.9 | 3.5 |
| Net Change In Cash and Cash Equivalents | -555.1 | 619.6 | 74.2 |
| Cash and Cash Equivalents at Beginning of Period | 964.1 | 344.5 | 270.3 |
| Cash and Cash Equivalents at End of Period | 409 | 964.1 | 344.5 |
| Interest (net of amounts capitalized) | 94.6 | 94.4 | 111.9 |
| Income taxes | 188.1 | 259.6 | 228.2 |
| Property, plant and equipment expenditures included in Accounts Payable | 16.9 | 10.6 | 30.7 |
| VMS Trade name and other asset impairments | 0 | 357.1 | 0 |
Note: Segments
18.Segments Segment Information The Company operates three reportable segments: Consumer Domestic, Consumer International and Specialty Products Division. These segments are determined based on differences in the nature of products and organizational and ownership structures. Segment revenues are derived from the sale of the following products: Segment Products / Other Consumer Domestic Household and personal care products Consumer International Primarily personal care products SPD Specialty Products As of December 31, 2025, the Company holds a 50% ownership interest in Armand. The Company's 50% interest in ArmaKleen was sold to our joint venture partner in October of 2024. The transaction is not material to the Company’s results of operations or cash flows. The Company’s equity in earnings of Armand and ArmaKleen, totaling $7.9, $9.1, and $8.7 for the three years ending December 31, 2025, 2024 and 2023, respectively, are not included in a reportable segment. Our reportable segments comprise the structure used by our Chief Executive Officer, who has been determined to be the Chief Operating Decision Maker ("CODM") to make key operating decisions and assess performance. The CODM considers Income from Operations for evaluating performance of each segment and making decisions about allocating capital and other resources to each segment. Asset information and capital expenditures are not regularly provided to the CODM. The following tables present financial information relating to the Company’s segments for each of the three years in the period ended December 31, 2025: Year Ended December 31, 2025 Consumer Domestic Consumer International SPD Consolidating Reclassification(1) Total Consolidated Net Sales $ 4,774.8 $ 1,129.4 $ 299.0 - $ 6,203.2 Cost of sales 2,544.0 625.5 190.4 68.5 3,428.4 Gross Profit 2,230.8 503.9 108.6 (68.5 ) 2,774.8 Marketing expenses 532.7 172.7 3.5 - 708.9 Research and Development(2) 129.1 13.5 3.0 - 145.6 Selling, general and administrative expenses 648.2 201.5 61.5 (68.5 ) 842.7 Income from Operations 920.8 116.2 40.6 - 1,077.6 Year Ended December 31, 2024 Consumer Domestic Consumer International SPD Consolidating Reclassification(1) Total Consolidated Net Sales $ 4,732.3 $ 1,071.5 $ 303.3 $ - $ 6,107.1 Cost of sales 2,450.1 605.5 193.5 67.9 3,317.0 Gross Profit 2,282.2 466.0 109.8 (67.9 ) 2,790.1 Marketing expenses 538.5 156.9 2.7 - 698.1 Research and Development(2) 123.7 12.7 3.3 - 139.
Note: Commitments, Contingencies and
16.Commitments, Contingencies and Guarantees Commitments a. The Company has a partnership with a supplier of raw materials that mines and processes sodium-based mineral deposits. The Company purchases the majority of its sodium-based raw material requirements from the partnership. The partnership agreement terminates upon two years’ written notice by either partner. Under the partnership agreement, the Company has an annual commitment to purchase 240,000 tons of sodium-based raw materials at the prevailing market price. The Company is not engaged in any other material transactions with the partnership or the partner supplier. b. As of December 31, 2025, the Company had commitments of approximately $361.4. These commitments include the purchase of raw materials, packaging supplies and services from its vendors at market prices to enable the Company to respond quickly to changes in customer orders or requirements, as well as costs associated with licensing and promotion agreements. c. As of December 31, 2025, the Company had various guarantees and letters of credit totaling $9.1. d. In connection with the December 1, 2020 acquisition of the ZICAM® brand (the "Zicam Acquisition"), the Company deferred an additional cash payment of $20.0 related to certain indemnifications provided by the seller. The Company has withheld payment as of December 31, 2025 for any future indemnity obligations.In connection with the December 24, 2021 acquisition of the THERABREATH® brand (the "TheraBreath Acquisition"), the Company deferred payment of a $14.0 portion of the purchase price related to certain indemnity obligations provided by the seller. The deferred amount is payable in installments between two and four years from the closing, with the first installment payment of $2.0 paid in January 2024, an additional $5.9 paid in the first quarter of 2025. The Company paid a final amount of $5.0 in January 2026.In connection with the October 13, 2022 Hero Acquisition, the Company deferred an additional cash payment of $8.0 to satisfy certain indemnification obligations. The additional amount, to the extent not used in satisfaction of such indemnity obligations, is payable five years from the closing.In connection with the July 16, 2025 Touchland Acquisition, the business acquisition liability was contingent upon the achievement of certain 2025 net sales thresholds, and will require a cash payment of $159.0 in the first half of 2026.
Note: Long-Term Debt
11.Long-Term Debt Long-term debt consists of the following: December 31, December 31, 2025 2024 Long-term debt 3.15% Senior notes due August 1, 2027 $ 425.0 $ 425.0 Less: Discount (0.1 ) (0.1 ) 2.3% Senior notes due December 15, 2031 400.0 400.0 Less: Discount (0.5 ) (0.6 ) 5.6% Senior notes due November 15, 2032 500.0 500.0 Less: Discount (0.7 ) (0.8 ) 3.95% Senior notes due August 1, 2047 400.0 400.0 Less: Discount (2.1 ) (2.2 ) 5.0% Senior notes due June 15, 2052 500.0 500.0 Less: Discount (0.1 ) (0.1 ) Debt issuance costs, net (16.4 ) (16.6 ) Total long-term debt $ 2,205.1 $ 2,204.6 Commercial PaperUnder the Company’s commercial paper program, the Company may issue commercial paper notes up to an aggregate principal amount outstanding at any given time of $2,000.0. The maturities of the notes will vary but may not exceed 397 days. The interest rates on the notes will vary based on market conditions and the ratings assigned to the notes by the rating agencies designated in the agreement at the time of issuance. Subject to market conditions, the Company intends to utilize the commercial paper program as its primary short-term borrowing facility. If, for any reason, the Company is unable to access the commercial paper market, the Company's Revolving Credit Facility would be utilized to meet the Company’s short-term liquidity needs. The Company did not have any commercial paper outstanding as of December 31, 2025 or 2024. As of December 31, 2025, the Company had approximately $1,993.0 available through the Revolving Credit Facility and commercial paper program. 3.15% Senior Notes due August 1, 2027On July 25, 2017, the Company issued $425.0 aggregate principal amount of 3.15% Senior Notes due 2027 (the “2027 Notes”). The 2027 Notes bear interest at 3.15%. Interest on the 2027 Notes is payable semi-annually, on each February 1 and August 1. The 2027 Notes will mature on August 1, 2027 unless earlier retired or redeemed. 2.3% Senior Notes due December 15, 2031On December 10, 2021, the Company issued $400.0 aggregate principal amount 2.3% Senior Notes due 2031 (the “2031 Notes”). The 2031 Notes bear interest at 2.30%. Interest on the 2031 Notes is payable semi-annually, on each June 15 and December 15. The 2031 Notes will mature on December 15, 2031, unless earlier retired or redeemed. The Company used a portion of the proceeds to finance the TheraBreath Acquisition.5.6% Senior Notes due November 15, 2032On October 31, 2022, the Company issued $500.
Note: Income Taxes
12.Income Taxes The components of income before taxes are as follows: 2025 2024 2023 Domestic $ 876.6 $ 666.5 $ 872.4 Foreign 80.3 89.8 95.0 Total $ 956.9 $ 756.3 $ 967.4 The following table summarizes the provision for U.S. federal, state and foreign income taxes: 2025 2024 2023 Current: U.S. federal $ 129.5 $ 180.9 $ 159.1 State 31.7 45.2 40.9 Foreign 22.9 26.9 25.6 184.1 253.0 225.6 Deferred: U.S. federal 44.3 (64.5 ) (11.3 ) State (9.7 ) (15.7 ) (2.8 ) Foreign 1.4 (1.8 ) 0.3 36.0 (82.0 ) (13.8 ) Total provision $ 220.1 $ 171.0 $ 211.8 Deferred tax assets (liabilities) consist of the following at December 31, 2025 and 2024: 2025 2024 Deferred tax assets: Accounts receivable $ 7.2 $ 7.4 Deferred compensation 55.8 51.7 Pension, postretirement, and postemployment benefits 4.8 2.9 Inventory reserve 7.7 8.6 Sec 174 R&D capitalization 13.4 59.4 ASC 842 lease liabilities 32.9 0.0 Tax credit carryforwards/other tax attributes 9.1 5.1 International operating loss carryforwards 8.9 8.4 Other 18.1 8.8 Total gross deferred tax assets 157.9 152.3 Valuation allowances (17.1 ) (14.3 ) Total deferred tax assets 140.8 138.0 Deferred tax liabilities: Goodwill (311.0 ) (298.7 ) Trade names and other intangibles (579.2 ) (415.0 ) Property, plant, and equipment (96.2 ) (85.2 ) ASC 842 Right of Use assets (30.4 ) 0.0 Interest rate swaps (3.2 ) (3.7 ) Total deferred tax liabilities (1,020.0 ) (802.6 ) Net deferred tax liability $ (879.2 ) $ (664.6 ) Long term net deferred tax asset 7.7 4.6 Long term net deferred tax liability (886.9 ) (669.2 ) Net deferred tax liability $ (879.2 ) $ (664.6 ) The difference between tax expense and the tax that would result from the application of the federal statutory rate is as follows: 2025 Amount Percent Federal $ 119.0 63.2 % State 40.6 21.6 % Foreign 28.5 15.2 % Total Income Tax Paid $ 188.1 100.0 % 2025 Amount Percent U.S. Federal Statutory Tax Rate $ 200.9 21.0 % State and Local Income Taxes, Net of Federal Income Tax Effect (a) 17.4 1.8 Foreign Tax Effects 8.2 0.9 Effect of Cross-Border Tax Laws (3.1 ) -0.3 Tax Credits (6.2 ) -0.6 Changes in Valuation Allowances 3.2 0.3 Nontaxable or Nondeductible Items 5.2 0.5 Changes in Unrecognized Tax Benefits 1.0 0.1 Other Adjustments (6.5 ) -0.7 ASC 842 Right of Use Assets 26.5 2.8 ASC 842 Lease Liabilities (28.6 ) -3.0 Other (4.4 ) -0.5 Effective Tax Rate $ 220.1 23.
Note: Leases
9.Leases The Company leases certain manufacturing facilities, warehouses, office space, railcars and equipment. Leases with an initial term of twelve months or less are not recorded on the consolidated balance sheet. All recorded leases are classified as operating leases and lease expense is recognized on a straight-line basis over the lease term. For leases beginning in 2019, lease components (base rental costs) are accounted for separately from the nonlease components (e.g., common-area maintenance costs). For leases that do not provide an implicit rate, the Company uses its estimated secured incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. A summary of the Company’s lease information is as follows: December 31, December 31, Classification 2025 2024 Assets Right of use assets Other Assets $ 166.0 $ 182.3 Liabilities Current lease liabilities Accrued Expenses and Other Liabilities $ 23.9 $ 32.4 Long-term lease liabilities Deferred and Other Long-term Liabilities 153.0 168.5 Total lease liabilities $ 176.9 $ 200.9 Other information Weighted-average remaining lease term (years) 7.4 7.4 Weighted-average discount rate 5.2 % 4.6 % Twelve Months Twelve Months Twelve Months Ended Ended Ended December 31, 2025 December 31, 2024 December 31, 2023 Statement of Income Lease cost(1) $ 42.2 $ 40.2 $ 31.7 Twelve Months Twelve Months Ended Ended December 31, 2025 December 31, 2024 Other information Leased assets obtained in exchange for new lease liabilities(2) $ 15.4 $ 28.0 Cash paid for amounts included in the measurement of lease liabilities $ 42.5 $ 35.3 (1)Lease expense is included in cost of sales or SG&A expenses based on the nature of the leased item. Short-term lease expense is excluded from this amount and is not material. The Company also has certain variable leases which are not material. The noncash component of lease expense for the twelve months ended December 31, 2025, 2024 and 2023 was $32.7, $30.9 and $24.3, respectively, is included in the amortization caption in the consolidated statement of cash flows. (2)Leased assets obtained in exchange for new lease liabilities in 2025 consisted of $48.6 of real estate lease additions and $3.7 of equipment lease additions, net of modifications, offset by $36.9 in lease terminations resulting from the sale of the VMS business.
Note: Acquisitions
6.Acquisitions Touchland AcquisitionOn July 16, 2025, the Company completed the acquisition of Touchland Holding Corp ("Touchland"), the developer of TOUCHLAND® hand sanitizer products (the "Touchland Acquisition"). The Company paid $656.0, net of cash acquired, at closing and entered an agreement to pay an additional amount based on 2025 net sales thresholds which will result in a cash payment of $159.0 to be paid in the first half of 2026. In addition, the Company granted rights to Touchland’s founder to receive shares of our Common Stock valued at $50.0, with 50% of such shares vesting at each of the first-and-second-year anniversaries of the closing. The value of Common Stock received by Touchland's founder will be recognized as compensation expense ratably over the two-year vesting period if the individual continues to be employed by the Company. Payment of a $5.0 portion of the purchase price was deferred related to certain indemnification obligations provided by Touchland’s equity holders, which amount, to the extent not used in satisfaction of such indemnity obligations, is payable three years from the closing. The Touchland Acquisition was financed with cash on hand and is managed in the Consumer Domestic and Consumer International segments. Touchland’s annual net sales for the year ended December 31, 2024 were approximately $115.0 million. The preliminary fair values of the net assets at acquisition are set forth as follows: Accounts receivable $ 9.3 Inventory 25.8 Other current assets 1.3 Property, plant and equipment 5.5 Other long-term assets 2.1 Trade name 730.0 Customer relationship intangible asset 32.8 Goodwill 206.5 Accounts payable, accrued expenses and other liabilities (23.3 ) Business acquisition liabilities - short-term (140.0 ) Deferred income taxes (183.8 ) Deferred and other long-term liabilities (10.2 ) Cash purchase price (net of cash acquired) $ 656.0 The trade name and customer relationship intangible assets were valued using a discounted cash flow model and have a useful life of 20 years. The goodwill is a result of expected synergies from combined operations of the acquired business and the Company. Business acquisition liabilities were valued using a Monte Carlo simulation model. Pro forma results are not presented because the impact of the acquisition is not material to the Company’s consolidated financial results. The goodwill and other intangible assets associated with the Touchland Acquisition are not deductible for U.
Note: Cybersecurity Risk Management,
ITEM 1C. CYBERSECURITY Cybersecurity Risk Management and StrategyWe collect, use and store personal information of our employees, consumers and other third parties in the ordinary course of business. In addition, we sell certain products directly to consumers online and through websites, mobile apps and connected devices, and we offer promotions, rebates, loyalty and other programs through which our data systems may receive personal information. We recognize the importance of data privacy and security and are committed to safeguarding and protecting our information and any other information entrusted to us. We have developed and implemented a cybersecurity risk management program intended to protect the confidentiality, integrity, and availability of our critical systems and information which is integrated with our overall risk management program. Our cybersecurity risk management program includes a cybersecurity incident response plan to respond to security breaches and cyberattacks. Our cybersecurity incident response plan is part of our overall Information Security Program, which is led by the Company’s Vice President, Global Chief Information Security Officer (“CISO”) and overseen by the Company’s Executive Vice President, Chief Technology & Analytics Officer, and is designed to protect and preserve the confidentiality, integrity and continued availability of all information owned by, or in the care of, the Company, and the Company’s ability to operate. Our cybersecurity incident response plan includes controls and procedures for timely and accurate reporting of any material cybersecurity incident. We design and assess our program based on the National Institute of Standards and Technology (NIST) Cybersecurity Framework (CSF).
Note: Share Repurchases
14.Share Repurchases On October 28, 2021, the Board authorized a new share repurchase program, under which the Company may repurchase up to $1,000.0 in shares of Common Stock (the “2021 Share Repurchase Program”). The 2021 Share Repurchase Program does not have an expiration and replaced the 2017 Share Repurchase Program. As of December 31, 2025, there remains $228.9 of share repurchase availability under the 2021 Share Repurchase Program.In May 2025, the Company entered into an accelerated share repurchase ("ASR") contract with a commercial bank to purchase Common Stock. The Company paid $300.0 to the bank, inclusive of fees, and received 2.8 million shares in May 2025 and 0.3 million shares in August 2025 at an average total share price of $95.71. The Company purchased all 3.1 million shares under the evergreen share repurchase program and used cash on hand to fund the purchase price. In August and September 2025, the Company executed open market purchases of 3.2 million shares for $300.0, inclusive of fees, of which $170.0 was purchased under the evergreen share repurchase program and $130.0 was purchased under the 2021 Share Repurchase Program. The shares were purchased at an average share price of $92.81 and the Company used cash on hand to fund the open market purchases. In November and December 2025, the Company executed open market purchases of 3.6 million shares for $300.0, inclusive of fees, of which all 3.6 million shares were purchased under the 2021 Share Repurchase Program. The shares were purchased at an average share price of $83.59 and the Company used cash on hand to fund the open market purchases.
Long notes are shortened. The full text is in the filing.
Filings
Newest first, from SEC EDGAR
- Quarterly report (10-Q) ↗ Filed 30 Oct 2026
- Current report (8-K) ↗ Filed 30 Oct 2026
- Current report (8-K) ↗ Filed 29 Oct 2026
- Quarterly report (10-Q) ↗ Filed 31 Jul 2026
- Current report (8-K) ↗ Filed 31 Jul 2026
- Current report (8-K) ↗ Filed 5 May 2026
- Quarterly report (10-Q) ↗ Filed 1 May 2026
- Current report (8-K) ↗ Filed 1 May 2026
- Proxy statement (DEF 14A) ↗ Filed 19 Mar 2026
- Current report (8-K) ↗ Filed 30 Jan 2026
- Quarterly report (10-Q) ↗ Filed 31 Oct 2025
- Proxy statement (DEF 14A) ↗ Filed 20 Mar 2025
- Annual report (10-K) ↗ Filed 13 Feb 2025
- Annual report (10-K) ↗ Filed 15 Feb 2024
- Annual report (10-K) ↗ Filed 16 Feb 2023
Sources and methodology
- Data on this tab
- SEC EDGAR and our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.